FDA Inspection
Teva Canada LimitedTeva Canada Limited – FDA Inspection, May 31, 2019
Record Details
This FDA Inspection record concerns Teva Canada Limited, with an inspection on May 31, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 9f7e450f-6441-4f92-b847-fdeb6eccff4c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1097611
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Teva Canada Limited
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 3, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 11, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 14, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 9, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 27, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Teva Canada Limited
- FDA Inspection 1225068 - 2023-11-03
- FDA Inspection 996651 - 2016-11-11
- FDA Inspection 865481 - 2014-02-14
- FDA Inspection 771387 - 2012-03-09
- FDA Inspection 566753 - 2009-02-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.